To assess current practice patterns for dry eye patients in South Korea and to evaluate the preference according to the ages and clinic types of physicians.
Dry eye patients (n = 1,612) were enrolled in this multicenter cross-sectional, observational study. The severity level of dry eye patients was classified based on the Korean guidelines for dry eye treatment. The medical records of the enrolled dry eye patients were evaluated, and the practice styles and the preferences were analyzed according to the ages and clinic types of physicians.
Of all patients, dry eye level 1 was most common (47.5%), followed by level 2 (33.5%), level 3 (9.1%), and level 4 (1.1%). Topical anti-inflammatory agents were used in 70.7% of patients with dry eye level 2 and in 80.6% of patients at levels 3 and 4. Topical anti-inflammatory agents were also used in 48.7% of patients with dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. The use of topical anti-inflammatory agents did not differ with investigator ages, but older physicians preferred preserved artificial tears more than younger ones. Physicians at referral hospitals also tended to use topical anti-inflammatory agents and preservative-free artificial tears earlier, beginning at dry eye level 1, than those who worked at private eye clinics.
Topical anti-inflammatory agents were commonly prescribed for the treatment of dry eye patients in South Korea, even from dry eye level 1. Preservative-free artificial tears were preferred at all dry eye levels. Practice styles differed somewhat depending on the ages and clinic types of physicians.
As the pathophysiology of dry eye has been established based on many studies, inflammation on the ocular surface is considered to be both a main cause as well as a consequence of dry eye disease [
Treatment guidelines for dry eye are not strict regulations but rather are useful methods to help physicians treat dry eye patients based on scientific evidence. In general, treatment recommendations are guided by the disease's severity. However, the available treatments for each severity level sometimes fail to relieve symptoms and signs of dry eye in patients. In these cases, treatment recommendations for higher severity levels can be used in clinical practice. Although several treatment guidelines for dry eye patients have been reported so far [
In this study, we assessed the actual clinical practice pattern for dry eye patients in South Korea and analyzed the practice styles and preferences according to the ages and clinic types of physicians.
This nonrandomized multicenter study was conducted over a six-month period from March to August 2010. Fifty investigators from 37 institutions who were all cornea specialists participated in this study. Prior to the present study, these investigators established new Korean guidelines for dry eye treatment during a group discussion (
During the study period, physicians completed a medical record on each new patient with dry eye who presented to their practices, including information on the severity level and their specific therapy choices. Although treatment decisions were made with reference to the guidelines, physicians were free to recommend any therapy to any particular patient based on their clinical judgment. The medical records of dry eye patients who were treated by one of our investigators during a six-month period were evaluated, and the current practice pattern for each level was analyzed. This study was approved by the respective institutional review boards of the 37 institutions where each investigator worked.
To determine whether the treatment recommendations differed depending on the physicians' ages and clinic types, the use of topical anti-inflammatory eye drops and the choice of artificial tears were evaluated and compared. The age distribution of the investigators was 30 to 39 years (n = 6), 40 to 49 years (n = 20), 50 to 59 years (n = 22), and 60 to 69 years (n = 2). Eight investigators worked at private eye clinics, while the remainder practiced medicine at referral hospitals.
Statistical analyses were performed using Fisher exact test with the SPSS ver. 12.0 (SPSS Inc., Chicago, IL, USA). Results were considered statistically significant if the
The 50 physicians enrolled 1,612 patients with dry eye during the study period. The mean age of patients was 56.9 (±13.2) years (range, 19 to 85 years), and 81% were female. The distribution of dry eye severity level is shown in
Topical anti-inflammatory agents were used in 70.7% of patients with dry eye level 2 and in 80.6% of patients at levels 3 and 4. Interestingly, topical anti-inflammatory agents were also used in 48.7% of patients with dry eye level 1 even though treatment guidelines recommend the use of topical anti-inflammatory agents only from dry eye level 2 and up (
Preservative-free artificial tears were preferred at all dry eye levels (
Gels or ointments were prescribed in 17.8% of patients with dry eye level 1, 20.6% of patients with dry eye level 2, and 40% of patients with dry eye levels 3 and 4. Essential fatty acids were recommended in fewer than 5% of patients at all dry eye levels. Additionally, oral tetracyclines were not used very often at dry eye levels 1 and 2, although they were prescribed to 7.3% of patients with dry eye levels 3 and 4 (
The percentage of dry eye patients who were treated with topical anti-inflammatory agents was similar at all dry eye levels among the three different physician age groups (
The use of topical anti-inflammatory agents was significantly different at dry eye level 1 and level 2 depending on the clinic type of the participating physicians (
This study is the first multicenter study for dry eye patients in South Korea. Fifty cornea specialists from 37 institutions participated in this study, and 1,612 patients with dry eye were enrolled over a six-month period. The distribution of dry eye severity levels showed a predominance of levels 1 and 2: 81.0% of patients fit into these two groups, with 47.5% for level 1 and 33.5% for level 2. A previous study of 183 enrolled patients with dry eye reported that severity level 2 was most frequent (59%), followed by level 1 (35%) [
Although most treatment guidelines for dry eye recommend the use of topical anti-inflammatory agents from dry eye level 2, topical anti-inflammatory agents were used for many patients with level 1 dry eye in actual clinical practice. This study showed that topical anti-inflammatory agents were used in 48.7% of patients with dry eye level 1. The aforementioned study also reported that level 2 treatments were prescribed for 43% of patients diagnosed at severity level 1 and suggested that this might be a consequence of physicians' increased awareness that aggressive, early treatment might slow or prevent the disease's progression [
In the Korean guidelines for dry eye, level 1 treatment options include patient education and preserved or non-preserved artificial tears, whereas level 2 treatment choices range from preservative-free artificial tears to topical anti-inflammatory agents, gels or ointments, and oral essential fatty acid supplementation. Although preserved or non-preserved artificial tears could be used for patients with dry eye level 1, 76.3% of patients were prescribed non-preserved artificial tears. The percentage of non-preserved artificial tears increased as the dry eye severity level increased. Benzalkonium chloride is most frequently used in topical ophthalmic preparations as well as in topical lubricants, and its epithelial toxicity has been well established [
Practice styles differed somewhat depending on physician age and clinic types. The use of topical anti-inflammatory agents was not different between the three age groups, whereas specific therapy choices among topical anti-inflammatory agents were significantly different. Although physicians in their 40s showed a tendency to use 0.05% topical cyclosporine more often than those in other age groups, there was no specific pattern as a physician aged. However, older physicians used preserved artificial tears more frequently. This may reflect a tendency of older physicians to continue the use of their past practice styles, even though the elimination of preservatives from lubricants is one of the most critical advances in the treatment of dry eye. The use of topical anti-inflammatory agents and the choice of artificial tears were significantly different depending on the clinic types of physicians. Physicians working at referral hospitals tended to use topical anti-inflammatory agents and preservative-free artificial tears earlier, beginning at dry eye level 1. This trend may be because most of the patients who had been referred had not responded to treatment with preserved artificial tears at the private eye clinics that referred them.
This study had a limitation. Although multicenter studies have several benefits, such as a large number of participants, different geographic locations and the ability to compare results among centers, they often lack conformity of data, which may compromise the ability to pool data in a standardized manner. In this study, the severity level of dry eye might differ somewhat according to diagnosing physicians even though the Korean guidelines for dry eye treatment were exclusively used for standardization.
In conclusion, topical anti-inflammatory agents are often used in the treatment of dry eye patients in South Korea, even beginning at dry eye level 1. Preservative-free artificial tears are preferred at all dry eye levels. Practice styles are somewhat different depending on the age and clinic type of physicians.
This study was supported by an unrestricted educational grant from Allergan Inc. (Irvine, CA, USA).
No potential conflict of interest relevant to this article was reported.
The distribution of dry eye severity levels.
The use of topical anti-inflammatory agents at each dry eye level.
Specific choices from topical anti-inflammatory agents at each dry eye level. Cs A = topical cyclosporin.
The use of artificial tears with or without preservatives at each dry eye level.
Specific choices from artificial tears at each eye level. HA = hyaluronic acid; CMC = carboxymethylcellulose.
Dry eye severity grading scheme for Korean dry eye guidelines
Treatment recommendations at each dry level for Korean dry eye guidelines
Percentage of patients treated with gels or ointments, essential fatty acids, and oral tetracyclines at each dry eye level
Percentage of patients treated with topical anti-inflammatory agents at each dry eye level according to the age of physicians
Specific choices for topical anti-inflammatory agents at each dry eye level according to physician age
Values are presented as %.
Cs A = topical cyclosporin.
Use of artificial tears at each dry eye level according to physician age
Values are presented as %.
Use of topical anti-inflammatory agents at each dry eye level according to the clinic types of physicians
Values are presented as %.
Choice of artificial tears at each dry eye level according to the clinic types of physicians
Values are presented as %.